Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isobaric versus hyperbaric intrathecal bupivacaine with dexmedetomidine for ureteroscopy
PACTR202510870626454Phase 2Completed
- Sponsor
- Mansoura University
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bupivacaine and dexmedetomidine (2 arms), sponsored by Mansoura University. Primary endpoint: Cardiac Index (CI) measurements. Started Jul 2024; status: completed.
02
Drugs
bupivacainedexmedetomidine
Beyond the preview
Go deeper on PACTR202510870626454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202510870626454.